E Hollander

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi B lymphocyte antigen D8/17 and repetitive behaviors in autism
    E Hollander
    Department of Psychiatry and the Seaver Autism Research Center, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
    Am J Psychiatry 156:317-20. 1999
  2. ncbi Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient
    E Hollander
    Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 60:27-31. 1999
  3. ncbi Impulsivity
    E Hollander
    Department of Psychiatry and the Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    J Psychopharmacol 14:S39-44. 2000
  4. ncbi Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report
    E Hollander
    Department of Psychiatry and the Seaver Autism Research Center, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Child Neurol 15:132-5. 2000
  5. ncbi Feeling unreal: a PET study of depersonalization disorder
    D Simeon
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Am J Psychiatry 157:1782-8. 2000
  6. ncbi Short-term single-blind fluvoxamine treatment of pathological gambling
    E Hollander
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Am J Psychiatry 155:1781-3. 1998
  7. ncbi Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging
    M M Haznedar
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    Am J Psychiatry 157:1994-2001. 2000
  8. ncbi An open trial of divalproex sodium in autism spectrum disorders
    E Hollander
    Department of Psychiatry and Seaver Autism Research Center, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
    J Clin Psychiatry 62:530-4. 2001
  9. ncbi Body dysmorphic disorder
    A Allen
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Psychiatr Clin North Am 23:617-28. 2000
  10. doi Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine
    S Pallanti
    Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
    J Psychopharmacol 24:847-53. 2010

Collaborators

Detail Information

Publications23

  1. ncbi B lymphocyte antigen D8/17 and repetitive behaviors in autism
    E Hollander
    Department of Psychiatry and the Seaver Autism Research Center, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
    Am J Psychiatry 156:317-20. 1999
    ..The authors examined the rate of D8/17 expression in children with autism and its correlation with severity of repetitive behaviors...
  2. ncbi Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient
    E Hollander
    Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 60:27-31. 1999
    ..Additionally, depression and suicide are frequent complications of BDD. Pharmacologic and nonpharmacologic treatments for the management of BDD with coexisting social anxiety are presented in this article...
  3. ncbi Impulsivity
    E Hollander
    Department of Psychiatry and the Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    J Psychopharmacol 14:S39-44. 2000
    ....
  4. ncbi Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report
    E Hollander
    Department of Psychiatry and the Seaver Autism Research Center, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Child Neurol 15:132-5. 2000
    ..Controlled treatment trials with venlafaxine are warranted in autism spectrum disorders...
  5. ncbi Feeling unreal: a PET study of depersonalization disorder
    D Simeon
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Am J Psychiatry 157:1782-8. 2000
    ..The goal of this study was to assess brain glucose metabolism and its relationship to dissociation measures and clinical symptoms in DSM-IV depersonalization disorder...
  6. ncbi Short-term single-blind fluvoxamine treatment of pathological gambling
    E Hollander
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Am J Psychiatry 155:1781-3. 1998
    ..The authors' goal was to assess the efficacy and tolerability of the selective serotonin reuptake inhibitor fluvoxamine in the treatment of pathological gambling...
  7. ncbi Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging
    M M Haznedar
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    Am J Psychiatry 157:1994-2001. 2000
    ....
  8. ncbi An open trial of divalproex sodium in autism spectrum disorders
    E Hollander
    Department of Psychiatry and Seaver Autism Research Center, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
    J Clin Psychiatry 62:530-4. 2001
    ..Divalproex sodium is indicated as both an anticonvulsant in epilepsy and a mood stabilizer in bipolar illness and thus might be useful for these complicating symptoms in autism...
  9. ncbi Body dysmorphic disorder
    A Allen
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Psychiatr Clin North Am 23:617-28. 2000
    ..Investigations in brain imaging and genetics are underway. Research in pharmacotherapy and CBT, individually and combined, is needed to refine, extend, and optimize treatment...
  10. doi Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine
    S Pallanti
    Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
    J Psychopharmacol 24:847-53. 2010
    ..This peripheral noradrenergic dysfunction could be consistent with attenuated cortico-frontal noradrenergic function as shown in positron emission tomography (PET) studies of PG...
  11. ncbi A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder
    E Hollander
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    J Clin Psychiatry 62:199-203. 2001
    ..Since anticonvulsant agents may be helpful in such symptomatology, we compared divalproex sodium with placebo in patients with borderline personality disorder...
  12. ncbi Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study
    M S Buchsbaum
    Neiroscience PET Laboratory, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
    Int J Neuropsychopharmacol 4:119-25. 2001
    ..These results are consistent with those in depression indicating that higher cingulate gyrus metabolic rates at baseline predict SRI response...
  13. ncbi Pharmacotherapy for obsessive-compulsive disorder
    E Hollander
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Psychiatr Clin North Am 23:643-56. 2000
    ..Augmentation and monotherapy have been explored with serotonergic enhancers, dopamine and 5-HT antagonists, enhancers of second-messenger systems, and GABAergic agents with varying efficacy...
  14. pmc Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity
    J D Buxbaum
    Laboratory of Molecular Neuropsychiatry, Mount Sinai School of Medicine, New York, NY, 10029, USA
    Am J Hum Genet 68:1514-20. 2001
    ....
  15. doi Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response
    S Pallanti
    Department of Psychiatry, Mount Sinai School of Medicine, Bronx, New York, NY, USA
    Neuropsychobiology 65:227-35. 2012
    ..We investigated the clinical, cognitive and neurophysiologic effects of a 3 weeks' protocol of low-frequency rTMS applied over the right DLPFC in resistant depression...
  16. doi Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study
    D Simeon
    Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine and Beth Israel Medical Center, 317 East 17th Street, New York, NY, USA
    Psychoneuroendocrinology 36:1418-21. 2011
    ..013). Results suggest that oxytocin may have a beneficial impact on emotional regulation in BPD, which merits further investigation and could have important treatment implications...
  17. ncbi Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder
    D Simeon
    Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
    Neuropsychopharmacology 25:793-5. 2001
    ..The purpose of this preliminary study was to investigate HPA axis function in dissociation...
  18. ncbi Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder
    S J Mathew
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    Depress Anxiety 14:199-208. 2001
    ..The limitations of IV CMI as a specific probe of serotonin function are discussed...
  19. ncbi Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19
    J D Buxbaum
    Laboratory of Molecular Neuropsychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Mol Psychiatry 9:144-50. 2004
    ..The data suggest that there is an autism susceptibility gene on chromosome 1 and provide further support for the presence of autism susceptibility genes on chromosomes 6 and 19...
  20. ncbi Diagnosis and treatment of obsessive-compulsive disorder and related disorders
    B Dell'Osso
    Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY, USA
    Int J Clin Pract 61:98-104. 2007
    ....
  21. ncbi Dermatology and conditions related to obsessive-compulsive disorder
    D J Stein
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032
    J Am Acad Dermatol 26:237-42. 1992
    ..Many of these disorders, which include trichotillomania, neurotic excoriation, onychophagia, body dysmorphic disorder, and dermatitis artefacta may respond to specific therapeutic interventions...
  22. ncbi Heat shock protein 90 antibodies in autism
    M Evers
    Department of Psychiatry, Seaver Autism Research Center, Mt Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029 6574, USA
    Mol Psychiatry 7:S26-8. 2002
  23. ncbi The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions
    M C Rosario-Campos
    Department of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Mol Psychiatry 11:495-504. 2006
    ....